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Abstract 
Optical coherence tomography (OCT) has potential as a modality for in vivo imaging of non-
melanoma skin cancer (NMSC). By allowing identification of sub-surface margins of NMSC 
lesions, the use of OCT could improve the rate of complete excision and reduce the average 
number of stages during Mohs micrographic surgery (MMS). The objective of this study was 
to use OCT to delineate the apparent sub-surface margins of NMSC lesions prior to their 
excision by MMS. Lesions were scanned with reference to a physical marker on the skin, and 
the apparent margins were then identified from the OCT images and marked on the skin. 
Photographs of these margins and the Mohs defect were correlated and compared. OCT 
appears capable of visualizing the transition from lesional to normal tissue. In this case 
study, margins marked by use of the OCT system before surgery exhibit excellent correlation 
with the MMS defect. OCT offers the promise of better outcomes by enabling accurate 
margin mapping of NMSC in advance of MMS. Priorities now are to demonstrate this 
capability in a larger study, and to understand clearly indications and contraindications for 
use. 
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Background 
Optical coherence tomography (OCT), a non-invasive optical imaging technique, is a 
biomedical technology used to characterize tissue microstructure. OCT is routinely 
utilized in ophthalmology for retinal imaging, and is continually evolving as a 
technology to image a wide variety of other tissue types, including skin [1]. OCT has 
similarities to ultrasound, providing real-time cross-sectional representation of tissue, 
but OCT enables higher resolution through its use of optics rather than acoustics. 
While the skin surface is easily examined by visual inspection, skin imaging 
technologies are appealing because they enable visualization of deeper cutaneous 
structures. However, the dense architecture, light-scattering properties, and small size 
of relevant anatomic components present challenges to imaging human skin. Standard 
imaging techniques such as CT and MRI, in their commonly used forms, can lack the 
resolution necessary for meaningful depiction of skin structure. Ultrasound does better, 
but studies have found it to offer no significant advantage over clinical inspection for 
determination of lesion extent [2], and it has not performed as well as OCT in 
determining lesion depth [3]. 
In contrast, confocal microscopy depicts the skin sub-surface with good resolution 
but limited depth. OCT offers the possibility of high resolution skin imaging without 
compromising depth, and OCT techniques have been applied in a variety of cutaneous 
disorders, including malignancies, inflammatory dermatoses, skin infections, and 
vascular lesions [4, 5]. 
Recently, a multi-beam OCT system enabling high-resolution tissue imaging was 
introduced to commercial markets, providing lateral resolution of >7.5 μm over a 1-mm 
focal range. This is twice the lateral resolution of existing commercial single beam 
systems over a similar focal depth, based around the limitations of beam waist 
diameter over a given Raleigh range in a fixed-focus Fourier domain implementation 
[6]. 
This modality has been used previously for the imaging of oral and gastrointestinal 
malignancies [7, 8], and its high-resolution capability is promising for investigation of 
skin architecture. When applied to skin, OCT enables visualization of relevant structural 
elements such as the dermal-epidermal junction, dermal papillae, cutaneous 
vasculature, and stratum corneum thickness [9–13]. Additionally, OCT allows 
convenient design features, such as a compact, lightweight hand-held probe and a user-
friendly interface presenting b-mode cross-sectional images in real time, requiring 
minimal operator training. The combination of its high resolution and ease of use could 
facilitate the application of multi-beam OCT technology for skin imaging. 
OCT offers potential for in vivo imaging of non-melanoma skin cancer (NMSC). NMSC 
are the most common human cancers, collectively conferring high morbidity and 
consuming substantial healthcare resources. Because early diagnosis of NMSC provides 
the greatest chance of cure, and as the current diagnostic standard for NMSC requires 
excision of tissue for histopathologic analysis, a non-invasive method for evaluation of 
clinically suspicious lesions could be highly useful as a diagnostic paradigm for NMSC. 
Ideally, OCT images can characterize skin microstructures non-invasively.   
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In the context of Mohs micrographic surgery (MMS), the gold standard and a 
commonly employed treatment approach for NMSC, imaging information can be used to 
guide the clinical approximation of tumor boundaries prior to excision. If the imaging 
capabilities of multi-beam OCT could facilitate delineation of lesion borders a priori, 
then the use of this technology in conjunction with MMS might decrease the average 
number of excised layers per case, shortening the duration of the procedure and 
reducing cost. Furthermore, MMS provides an ideal framework for the initial evaluation 
of multi-beam OCT imaging in cutaneous models, since it allows for cross-correlation of 
OCT-derived visual information with confirmed histologic margins. The goal of this 
pilot study is to examine the feasibility of multi-beam OCT for use in MMS by applying 
this technology to predict the lateral boundaries of a basal cell carcinoma (BCC). 
Materials and Methods 
A single patient with biopsy-proven BCC on the left cheek, presenting for MMS, is documented in 
this manuscript. Consent was obtained in accordance with an Investigational Review Board-approved 
protocol (Independent Investigational Review Board, Plantation, Fla., USA). 
This study used a commercially available, FDA 510(k)-cleared OCT system (VivoSight; Michelson 
Diagnostics, Orpington, UK). 
A series of pen marks were made on the skin some distance from the BCC lesion, allowing 
photographs from before, during and after the MMS procedure to be correlated. The lesion was 
photographed to establish a baseline, using both a standard camera (Canon Ixus 120 IS; Canon, Tokyo, 
Japan) in macro mode and a digital dermatoscope (DermLite FOTO; 3Gen, San Juan Capistrano, Calif. 
USA) on a Coolpix 995 camera (Nikon, Tokyo, Japan). 
An adhesive paper ring (hole reinforcements; WH Smith, UK) was affixed to the skin such that the 
hole was centered on the clinically apparent lesional margin. Two marks were made on the ring, 
separated by 90 degrees, to allow the probe orientation to be recorded. With the probe applied gently 
to the skin, the OCT instrument was then used to take a series of fifty 5-mm wide × 2 mm deep cross-
sectional images of the region enclosed by the ring, with each image separated by 0.1 mm so that a 
total area of 5 × 5 mm was evenly sampled. It was possible to visualize about 1.25 mm into the skin of 
this particular patient. The images were then viewed, and based on visualization of morphological 
features within the sample, the apparent transition point between tumor and benign perilesional skin 
was identified. This judgment was aided by reference to a ‘normal’-appearing skin sample 
contralateral to the lesion, which was imaged first to serve as a frame of reference for evaluating the 
patient’s local skin morphology. By reference to the imaging frame number and the adhesive ring, the 
frame containing the identified transition point could be transposed to a point on the patient’s skin, 
and a mark was made to denote the predicted margin. This procedure was repeated an additional 
three times, so that the superior, inferior, lateral, and medial lesion boundaries were delineated. An 
additional photograph was then taken to record the predicted tumor margins.  
The Mohs procedure was then performed in the usual fashion, with no reference to the indicated 
borders determined by OCT analysis. Once the margins were found to be clear of tumor under frozen-
section analysis, an additional photograph showing both the Mohs defect and the previously drawn 
alignment marks was taken. By superimposing and aligning the marks, the accuracy of the OCT-
derived margin could be compared to that achieved by the Mohs procedure. 
Results 
The BCC lesion was removed by MMS in two stages. The pre-operative margins 
determined by OCT imaging, the final MMS defect, and a composite image in which the 
two photographs are aligned using the reference markers are shown (fig. 1). The  
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margins marked by use of the OCT system before surgery closely approximate the final 
two-stage MMS defect on all sides. Also shown are examples of the OCT images at the 
tumor margin and within the tumor (fig. 2). 
Discussion 
We report the use of multi-beam OCT to predict the boundaries of a BCC prior to 
MMS excision, with good correlation between OCT-aided lesion mapping and MMS. 
Interestingly, the boundaries of this particular BCC extended beyond the clinically 
apparent extent of tumor, and were successfully predicted by OCT in advance of an 
MMS procedure that required two stages. This finding suggests that OCT might be a 
useful adjunct to MMS, by revealing lateral tumor margins that extend beyond apparent 
surface cues. The use of OCT could potentially reduce the number of layers required for 
MMS and minimize removal of perilesional benign tissue. This case study provides 
further evidence that OCT can be used to identify NMSC tumor margins, and a larger 
prospective trial of OCT imaging in conjunction with MMS is currently underway. 
The use of OCT to image NMSC depends on recognizing characteristic features of 
normal skin and NMSC. The challenge now is to reduce the subjectivity of such 
judgments. A detailed atlas of OCT features correlated with well-understood 
dermatopathological features, along with a quantitative analysis of the physical basis 
for OCT signal intensity as a function of tissue type, will go a long way to addressing 
this concern. 
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Fig. 1. a Margins of the tumor, marked using OCT prior to surgery. Arrows labeled (1) show reference 
marks for correlation of photographies. Arrows labeled (2) show marks indicating the extent of the 
lesion identified by OCT. b Mohs defect at the end of the second stage. The image appears as a 
composite with the Mohs defect set at 100% opacity to ensure that the scale and orientation are 
identical to a and c. c Image b above overlaid on a. The lesional margins identified by OCT imaging 
closely approximate the Mohs defect. 
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Fig. 2. a Lesional margin, as determined by OCT imaging. Note the complete and uninterrupted 
dermal-epidermal junction (DEJ) and the thin and regular stratum corneum (SC), which is almost 
entirely obscured by the entrance port (inset). b Within BCC lesion, 0.5 mm from the margin shown in 
a. Note the disruption of the DEJ and the slightly thickened SC just visible above the entrance port. 
Also notable are the lower general signal in the dermis, and the large hyporeflective areas. 
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